Urokinase plasminogen activator system as a potential target for cancer therapy

Author： Mekkawy Ahmed H Morris David L Pourgholami Mohammad H

ISSN： 1479-6694

Source： Future Oncology, Vol.5, Iss.9, 2009-11, pp. : 1487-1499

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Urokinase-type Plasminogen Activator System in Prostate Cancer Metastasis

By Sheng S.

Cancer and Metastasis Reviews, Vol. 20, Iss. 3-4, 2001-12 ,pp. : 287-296

Springer Publishing Company

Access to resources Recommend Favorite

Disregulation of Urokinase Plasminogen Activator Gene in Breast Cancer

By Hubbard A.L. Lauder J. Hawkins R.A. Anderson T.J.

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 103-107

Elsevier

Access to resources Recommend Favorite

Novel Patents and Cancer Therapies for Transforming Growth Factor- Beta and Urokinase Type Plasminogen Activator: Potential Use of Their Interplay in Tumorigenesis

Recent Patents on Anti-Cancer Drug Discovery, Vol. 9, Iss. 3, 2014-09 ,pp. : 354-371

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 637-645

Spandidos Publications

Access to resources Recommend Favorite

Detection of cathepsin B, cathepsin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patients

Oncology Letters, Vol. 2, Iss. 4, 2011-01 ,pp. : 693-699

Spandidos Publications

Access to resources Recommend Favorite